Biography of toxin

Timerbayeva S. in Russian. Jankovic J. Botulinum Toxin: state of the art. Mov Disord. Botulinum Neurotoxin Formulations: overcoming the confusion. Clin Cosmet Investig Dermatol. Toxins Basel. New Trends in Botulinum Toxin Use in Dermatology. Dermatol Pract Concept. Plast Reconstr Surg. A Review of the Longevity of Effect of Botulinum Toxin in Wrinkle Treatments.

Br Dent J. Aesthetic Use of Bont: Options and Outcomes. Botulinum Toxin Off-Label Use in Dermatology: A Review. Skin Appendage Disord. J Cosmet Dermatol. J Drugs Dermatol. The Safety and Efficacy of Botulinum Toxin for Management of Scars: ASTEMATIC Review with Meta-ANALISISIS AND TRIALE SEQUENTIAL ANALYSIS. Botulinum Toxin for the Treatment of Refractory Erythema and Flushing of Rosacea.

Experience with Botulinum Toxin Therapy for Axillary Hyperhidrosis and Comparison to Modelled Data Endoscopic Thoracic Sympathemy - a Quality of Life and Cost Effectivence Analysis. Efficacy and Possible Muchanisms of Botulinum Toxin Treatment of Oily Skin. A Small Dose of Botulinum Toxin a is Effective for Treating Androgenetic Alopecia in Chinese Patients. Dermatol Ther.

Auxiliary Usage of Botulinum Toxin a in Plastic Surgery in China. Ann Chir Plast Esthet. Ann Plast Surg. Aesthet Surg J. Plastic and Reconstibe Surgery. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. Pharmacol Rev. The Potential Effect of Botulinum Toxin Type a on Human Dermal Fibroblasts: An in Vitro Study. Dermatol Surg. The Effect of Botulinum Toxin Type a In Different Dilution On the Contract of Fibroblast i N Vitro Study.

Int j mol med. Botulinum Toxin Type a Inhibits Connective Tissue Growth Factor Expression in Fibroblasts Derved from Hypertrophic Scar. Aesthetic Plast Surg. Effect of Botulinum Toxin Type a on Transforming Growth Factor Beta1 in Fibroblasts Derved from Hypertrophic SCAR: A Preliminary Report. Plast Reconstr Surg Glob Open. Botulinum Toxin Drugs: Brief History and Outlook.

J Neural Transm Vienna. Botulinum Neurotoxin Formulations: Overcoming the Confusion [Publice Correction Appears in Clin Cosmet Investig Dermatol. Immunogenicity of Botulinum Toxins. Timerbaeva S. The InEffectivence of Botulinum Toxin Therapy: Old Problem, New Solutions. Nervnye Bolezni. Ratio of Units of Action of Various Botulinum Neuroprotein Preparations Wen Used in Neurological Practice.

Zhurnal Nevrologi I Psihiatrii. High Prevalence of Neutralizing Antibodies after Long-Term Botulinum Neurotoxin Therapy. Neurotox Res. EUR J Neurol. Immunogenicity Associated with Botulinum Toxin Treatment. Published Aug the Role of Antibody Production in the Formation of Resistance to Botulinum Toxin a in Aesthetic Practice. Rossijskij Zhurnal Kozhnyh I Venerichesh Boleznej.

Dressler D, Bigalke H. Immunological Aspects of Botulinum Toxin Therapy. Expert Rev Neurother. Antibody-induced Failure of Botulinum Toxin Therapy: Re-Start with Low-Antigenicity Drugs Offers AW Treatment Opportunity. Comparison Between Botulinum Neurotoxin Type A2 and Type A1 by Electrophyological Study in Healthy Individuals. Botulinum Toxin Type a Versus Botulinum Toxin Type B for Cervical Dystonia.

Cochrane Database Syst Rev. Publice Oct Clinical Differences Between Botulinum Neurotoxin Type a and B. J Neural Transm. Botulism: The Present Status of the Disease. Curr Top Microbiol Immunol. Botulinum Neurotoxin Cutants Reveal Different Effects of Syntaxin Or Snap Protelysis on Neuromuscular Transmission. PLOS PATHOG. Botulinum Neurotoxin Serotype C: A Novel Effective Botulinum Toxin Therapy in Human.

Neurosci Lett. Botulinum Neurotoxin Serotypes a and C Do Not Affect Motor Units Survival in Humans: An Electrophyological Study Motor Units Counting. Clin neurophysiol. Clinical Use of Non-a Botulinum Toxins: Botulinum Toxin Type C and Botulinum Toxin Type F. J Am Acad Dermatol. Mov Disord Clin Pract. Published Apr Botulinum Toxin Therapy for Osteoarticular Pain: An Evidence-Bassed Review.

Theer ADV Musculoskelet Dis. Botulinum Toxin Treatment of Myofascial Pain: A Critical Review of the Literature. Curr Pain Headache Rep. Mittal So, Jabbari B. Design of Modified Botulinum Neurotoxin A1 Variants with A Shorter Paralavsis and Duration of Action. In Vivo Onset and Duration of Action Varies for Botulinum Neurotoxin a Subtypes Nevrologiya, Nejropsihiatriya, Psihosomatika. Bruxism: Methods of Application and Results of Treatment with Botulinum Neuroprotein Relatox.

Nervno-Myshechnye Bolezni. Topical Issues of the Use of Botulinum Toxin Type a in the Treatment of Blepharmspasm. Botulinum Toxin Therapy of the Upper Third of the Face Drug of Domestic Production Relatox. Clinical Experience. Efficacy and Safety of ABOBOTULINUMTOXINA Liquid Formulation in Cervical Dystonia: A RANDOMIZED-CONTROLLED TRIAL.

Evaluation of QM, A Novel Ready-to -use Liquid Botulinum Toxin in Aesthetic Treatment of Glabellar Lines.Investigation of Safety, Toleability and Effectivence of Botulinum Toxin Type a in Liquid Form in Paty Facial Wrinkles and Blepharmspasm. Klinicheskaya dermatologiya I Venerologiya. Results of a Randomized, Double-Blind, Placebo-Controlled Study to Effety and Safety OF A BOTULINUM TOXIN TYPE A TOPICAL GEL TOTM Moderate-to-Everele Lateral Canthal Lines.

Glogau RG. Topically Applied Botulinum Toxin Type A for the Treatment of Primary Axillary Hyperhidrosis: Results of a Randomized, Blinded, Vehicle-Controlled Study. PEPTIDE-MEDIDEETED TRANSDERMAL DELivery of Botulinum Neurotoxin Type a Reduces Neurogenic InflamMation in the Skin. Botolinum Toxin in Rhinitis: Literature Review and Posterior Nasal Injection in Allergic Rhinitis.